End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.87 CNY | +3.38% | +5.60% | -22.26% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's profit outlook over the next few years is a strong asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- With an expected P/E ratio at 33.65 and 26 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.26% | 255M | - | ||
+5.16% | 212B | B | ||
+9.62% | 188B | B- | ||
+31.18% | 157B | B- | ||
+33.37% | 114B | A- | ||
+3.46% | 64.01B | A- | ||
+1.51% | 48.83B | B+ | ||
-4.27% | 39.3B | A | ||
+0.88% | 35.97B | - | ||
+8.44% | 27B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300562 Stock
- Ratings Guangdong Transtek Medical Electronics Co., Ltd